Achilles Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 215

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

Achilles Therapeutics General Information

Description

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Contact Information

Formerly Known As
AchillesTx, Achilles Therapeutics Limited, Achilles Tx
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 245 Hammersmith Road
  • London W6 8PW
  • England, United Kingdom
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 245 Hammersmith Road
  • London W6 8PW
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Achilles Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Liquidation 03-Feb-2025 Completed Bankruptcy: Liquidation
6. IPO 31-Mar-2021 Completed Clinical Trials - General
5. Later Stage VC (Series C) 19-Nov-2020 Completed Clinical Trials - General
4. Early Stage VC (Series B) 03-Sep-2019 Completed Clinical Trials - General
3. Early Stage VC (Series A) 13-Sep-2017 Completed Clinical Trials - General
2. Early Stage VC (Series A) 24-May-2016 $4.43M $4.43M Completed Startup
1. University Spin-Out 01-May-2016 Completed Startup
To view Achilles Therapeutics’s complete valuation and funding history, request access »

Achilles Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series B
Series A 17,850,000 $0.000012 $1.22 $1.22 1x $1.22 25.3%
To view Achilles Therapeutics’s complete cap table history, request access »

Achilles Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeti
Biotechnology
London, United Kingdom
215 As of 2023

Dallas, TX
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Achilles Therapeutics Competitors (26)

One of Achilles Therapeutics’s 26 competitors is Instil Bio, a Formerly VC-backed company based in Dallas, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Instil Bio Formerly VC-backed Dallas, TX
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Iovance Biotherapeutics Corporation San Carlos, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 26 competitors. Get the full list »

Achilles Therapeutics Patents

Achilles Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202407727-D0 Reporters constructs, systems and assays Inactive 31-May-2024
GB-202319691-D0 Immune assay Inactive 20-Dec-2023
GB-202316205-D0 Co-culture Inactive 23-Oct-2023
WO-2025083398-A1 Co-culture Inactive 16-Oct-2023
WO-2024256485-A1 Identification of neoantigen peptides Inactive 15-Jun-2023 G16B30/10
To view Achilles Therapeutics’s complete patent history, request access »

Achilles Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Achilles Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Syncona Venture Capital Minority
To view Achilles Therapeutics’s complete investors history, request access »

Achilles Therapeutics FAQs

  • When was Achilles Therapeutics founded?

    Achilles Therapeutics was founded in 2016.

  • Where is Achilles Therapeutics headquartered?

    Achilles Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Achilles Therapeutics?

    Achilles Therapeutics has 215 total employees.

  • What industry is Achilles Therapeutics in?

    Achilles Therapeutics’s primary industry is Biotechnology.

  • Is Achilles Therapeutics a private or public company?

    Achilles Therapeutics is a Private company.

  • What is Achilles Therapeutics’s current revenue?

    The current revenue for Achilles Therapeutics is .

  • How much funding has Achilles Therapeutics raised over time?

    Achilles Therapeutics has raised $390M.

  • Who are Achilles Therapeutics’s investors?

    Syncona has invested in Achilles Therapeutics.

  • Who are Achilles Therapeutics’s competitors?

    Instil Bio, Inovio Pharmaceuticals, Iovance Biotherapeutics, Kite Pharma, and Sarepta Therapeutics are some of the 26 competitors of Achilles Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process